MR1 and cancer: One, it highlights the need for a deeper understanding of non-MAIT, MR1-restricted TCRs prior to clinical translation; two, it raises the importance of deciphering the ligands driving reactivity in cancer and infection; and finally, it raises the specter that MR1 allele variants warrant understanding in the context of allotransplantation.